ERTAPENEM SODIUM

ERTAPENEM SODIUM was reported 7464 times

ERTAPENEM SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 166 0.5479
1 AVIAN INFLUENZA 13 0.2031
2 ARTERIAL ANGIOPLASTY 5 0.1852
3 BONE MARROW EOSINOPHILIC LEUKOCYTE COUNT INCREASED 5 0.1724
4 ALLERGIC HEPATITIS 5 0.1163
5 BAND NEUTROPHIL COUNT DECREASED 7 0.1061
6 RAOULTELLA ORNITHINOLYTICA INFECTION 8 0.1039
7 LEVATOR SYNDROME 4 0.1026
8 FEMALE GENITAL TRACT FISTULA 169 0.0989
9 RENAL GRAFT INFECTION 17 0.0733
10 MACULAR DEGENERATION 808 0.0676
11 RADICULOPATHY 167 0.0633
12 PROCTITIS 165 0.0588
13 CHRONIC SINUSITIS 219 0.0583
14 CHORIOCARCINOMA 4 0.0506
15 GRANULOMATOUS DERMATITIS 12 0.0492
16 AXONAL AND DEMYELINATING POLYNEUROPATHY 5 0.0490
17 URINARY TRACT INFLAMMATION 12 0.0333
18 MALACOPLAKIA 15 0.0328
19 BILIARY SEPSIS 15 0.0324
20 CONDUCTIVE DEAFNESS 10 0.0312
21 ENTEROCOLONIC FISTULA 4 0.0301
22 URINARY TRACT INFECTION PSEUDOMONAL 16 0.0266
23 CLOSTRIDIUM TEST POSITIVE 58 0.0263
24 DISORGANISED SPEECH 45 0.0244
25 RHODOCOCCUS INFECTION 4 0.0241
26 VITAMIN B1 DEFICIENCY 9 0.0211
27 FACTOR V INHIBITION 4 0.0206
28 NORMOCHROMIC ANAEMIA 4 0.0200
29 EMPHYSEMATOUS CYSTITIS 4 0.0188
30 EPILEPTIC ENCEPHALOPATHY 4 0.0179
31 SPLENIC ABSCESS 7 0.0172
32 MITOCHONDRIAL TOXICITY 14 0.0171
33 PLASMABLASTIC LYMPHOMA 6 0.0168
34 VAGINAL DISCHARGE 167 0.0165
35 HEPATIC INFARCTION 6 0.0159
36 INCISION SITE DISCHARGE 4 0.0158
37 GLOMERULONEPHROPATHY 4 0.0156
38 PARAESTHESIA ORAL 222 0.0154
39 EOSINOPHILIC PNEUMONIA ACUTE 13 0.0150
40 SERRATIA INFECTION 11 0.0148
41 PROSTATIC ABSCESS 4 0.0145
42 COLONIC FISTULA 8 0.0141
43 ORAL CANDIDIASIS 178 0.0135
44 ESCHERICHIA TEST POSITIVE 16 0.0134
45 HER2 POSITIVE BREAST CANCER 5 0.0133
46 ENTEROBACTER BACTERAEMIA 4 0.0132
47 TOXIC ENCEPHALOPATHY 65 0.0128
48 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 5 0.0123
49 UREAPLASMA INFECTION 5 0.0123
50 NEUROPSYCHOLOGICAL SYMPTOMS 7 0.0116
51 RHINOCEREBRAL MUCORMYCOSIS 4 0.0115
52 PSEUDOMONAL SEPSIS 20 0.0114
53 PATHOGEN RESISTANCE 102 0.0112
54 PSEUDOPOLYP 4 0.0111
55 CLONIC CONVULSION 8 0.0109
56 ACUTE PHASE REACTION 4 0.0105
57 NEUROMYOPATHY 11 0.0103
58 CONVULSIVE THRESHOLD LOWERED 4 0.0102
59 INFECTIVE ANEURYSM 5 0.0101
60 CLOSTRIDIUM DIFFICILE COLITIS 107 0.0101
61 THERAPEUTIC PRODUCT CROSS-REACTIVITY 9 0.0101
62 KLEBSIELLA BACTERAEMIA 9 0.0095
63 BELLIGERENCE 4 0.0093
64 ANTICONVULSANT DRUG LEVEL DECREASED 13 0.0092
65 ACINETOBACTER INFECTION 10 0.0091
66 METABOLIC ENCEPHALOPATHY 27 0.0090
67 EXTRADURAL ABSCESS 7 0.0089
68 RENAL ABSCESS 7 0.0085
69 MAGNESIUM DEFICIENCY 4 0.0085
70 DELAYED GRAFT FUNCTION 6 0.0084
71 PRE-EXISTING DISEASE 4 0.0082
72 CROSS SENSITIVITY REACTION 8 0.0082
73 ENDOTRACHEAL INTUBATION 23 0.0082
74 EOSINOPHILIC PNEUMONIA 25 0.0079
75 BREAST ABSCESS 8 0.0078
76 NEUROPSYCHIATRIC SYMPTOMS 7 0.0078
77 COGWHEEL RIGIDITY 8 0.0076
78 RESPIRATORY TRACT INFECTION FUNGAL 4 0.0076
79 KLEBSIELLA INFECTION 38 0.0075
80 ANAL STENOSIS 4 0.0075
81 CORYNEBACTERIUM INFECTION 4 0.0075
82 ENCEPHALOPATHY 176 0.0072
83 BONE FRAGMENTATION 4 0.0071
84 PROCEDURAL PAIN 197 0.0071
85 SEIZURE LIKE PHENOMENA 12 0.0071
86 FOOT AMPUTATION 10 0.0069
87 EOSINOPHILIC MYOCARDITIS 5 0.0068
88 ENTEROCUTANEOUS FISTULA 6 0.0068
89 POSTICTAL STATE 7 0.0067
90 STATUS EPILEPTICUS 75 0.0066
91 MYOCLONUS 77 0.0064
92 ABDOMINAL COMPARTMENT SYNDROME 4 0.0063
93 HYPERCHLORAEMIA 4 0.0063
94 FREQUENT BOWEL MOVEMENTS 169 0.0062
95 REFLEXES ABNORMAL 4 0.0062
96 BLOODY DISCHARGE 7 0.0061
97 WOUND SECRETION 24 0.0061
98 DYSBIOSIS 5 0.0061
99 MYASTHENIA GRAVIS CRISIS 9 0.0061
100 EPILEPSY 184 0.0060
101 PNEUMONIA KLEBSIELLA 11 0.0060
102 DEVICE RELATED SEPSIS 12 0.0060
103 ESCHERICHIA BACTERAEMIA 14 0.0059
104 STENOTROPHOMONAS INFECTION 8 0.0059
105 ESCHERICHIA URINARY TRACT INFECTION 25 0.0059
106 INTERVERTEBRAL DISCITIS 11 0.0058
107 HYPERTROPHIC CARDIOMYOPATHY 9 0.0058
108 TOOTH DISCOLOURATION 17 0.0058
109 TUMOUR NECROSIS 6 0.0057
110 SKIN ODOUR ABNORMAL 22 0.0056
111 LINEAR IGA DISEASE 9 0.0054
112 RASH MORBILLIFORM 15 0.0054
113 ENTEROBACTER INFECTION 9 0.0054
114 ENTEROCOCCAL INFECTION 25 0.0052
115 NEUROTOXICITY 90 0.0051
116 CLOSTRIDIUM DIFFICILE INFECTION 112 0.0051
117 INHIBITORY DRUG INTERACTION 8 0.0051
118 CEREBELLAR SYNDROME 11 0.0050
119 EXCESSIVE GRANULATION TISSUE 4 0.0050
120 LIVER ABSCESS 16 0.0049
121 REDUCED FACIAL EXPRESSION 5 0.0049
122 LEUKOCYTURIA 4 0.0049
123 CIRCADIAN RHYTHM SLEEP DISORDER 4 0.0048
124 INCISION SITE COMPLICATION 4 0.0048
125 TYPE IV HYPERSENSITIVITY REACTION 13 0.0047
126 ESCHERICHIA INFECTION 39 0.0047
127 ENTEROCOCCAL BACTERAEMIA 5 0.0047
128 APPENDICITIS PERFORATED 12 0.0047
129 GAZE PALSY 8 0.0047
130 COLITIS 178 0.0047
131 BILIARY OBSTRUCTION 6 0.0046
132 TONIC CLONIC MOVEMENTS 6 0.0046
133 PULMONARY CAVITATION 4 0.0046
134 PNEUMONIA PSEUDOMONAL 7 0.0046
135 COMPLEX PARTIAL SEIZURES 5 0.0045
136 HALLUCINATION, VISUAL 95 0.0045
137 ADENOVIRUS INFECTION 13 0.0045
138 PSEUDOMEMBRANOUS COLITIS 10 0.0045
139 DELIRIUM 150 0.0043
140 URINARY TRACT INFECTION ENTEROCOCCAL 4 0.0043
141 HIDRADENITIS 39 0.0043
142 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 33 0.0042
143 PNEUMOCYSTIS JIROVECII INFECTION 5 0.0042
144 HEPATITIS CHOLESTATIC 25 0.0041
145 RENAL INFARCT 6 0.0041
146 PCO2 DECREASED 4 0.0041
147 CLOSTRIDIUM COLITIS 5 0.0041
148 CONVULSION 230 0.0040
149 OTORRHOEA 7 0.0040
150 AMPUTATION 5 0.0040
151 RECTAL HAEMORRHAGE 170 0.0040
152 SERUM SICKNESS 11 0.0039
153 FUNGAEMIA 6 0.0038
154 OSTEOSCLEROSIS 6 0.0038
155 URETEROLITHIASIS 4 0.0038
156 HALLUCINATIONS, MIXED 16 0.0038
157 COLITIS ULCERATIVE 169 0.0038
158 GENERALISED TONIC-CLONIC SEIZURE 62 0.0037
159 GRAND MAL CONVULSION 34 0.0037
160 PRODUCT NAME CONFUSION 4 0.0037
161 NOSOCOMIAL INFECTION 8 0.0036
162 PARTIAL SEIZURES 19 0.0036
163 DRUG RESISTANCE 92 0.0036
164 KLEBSIELLA SEPSIS 4 0.0035
165 MULTIPLE-DRUG RESISTANCE 11 0.0035
166 ALVEOLITIS 5 0.0035
167 DIABETIC FOOT INFECTION 5 0.0035
168 TONIC CONVULSION 5 0.0035
169 HALLUCINATION 266 0.0035
170 SUBCLAVIAN VEIN THROMBOSIS 4 0.0035
171 MENTAL STATUS CHANGES 97 0.0035
172 FOLATE DEFICIENCY 4 0.0035
173 ACUTE PRERENAL FAILURE 4 0.0035
174 HEPATITIS TOXIC 9 0.0035
175 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 86 0.0033
176 INFUSION RELATED REACTION 221 0.0033
177 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 11 0.0033
178 MIXED LIVER INJURY 10 0.0033
179 PRODUCT PACKAGING CONFUSION 8 0.0033
180 SOFT TISSUE INFECTION 6 0.0033
181 HAEMATOCHEZIA 180 0.0033
182 CLOSTRIDIAL INFECTION 11 0.0032
183 OTOTOXICITY 6 0.0032
184 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 226 0.0032
185 ABDOMINAL ABSCESS 14 0.0032
186 NEPHRITIS INTERSTITIAL 4 0.0032
187 ABDOMINAL INFECTION 8 0.0031
188 ENDOCARDITIS 16 0.0031
189 LICHENOID KERATOSIS 7 0.0031
190 SLEEP TALKING 5 0.0029
191 INTESTINAL MASS 4 0.0029
192 CLONUS 8 0.0029
193 TRISMUS 15 0.0029
194 RHONCHI 4 0.0029
195 SPLENIC INFARCTION 5 0.0029
196 GLOMERULONEPHRITIS 7 0.0029
197 BRONCHIAL OBSTRUCTION 4 0.0028
198 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 27 0.0028
199 UROSEPSIS 26 0.0028
200 JUGULAR VEIN THROMBOSIS 5 0.0028
201 TRANSPLANT DYSFUNCTION 5 0.0028
202 OSTEITIS 7 0.0028
203 URINARY TRACT INFECTION BACTERIAL 7 0.0028
204 ESCHERICHIA SEPSIS 8 0.0028
205 PRODUCT PREPARATION ISSUE 18 0.0027
206 EOSINOPHILIA 48 0.0027
207 CONFUSIONAL STATE 441 0.0027
208 NORMOCYTIC ANAEMIA 4 0.0027
209 BACTERAEMIA 32 0.0027
210 BACTERIAL TEST POSITIVE 6 0.0027
211 RENAL TUBULAR NECROSIS 26 0.0026
212 THROMBOPHLEBITIS SUPERFICIAL 8 0.0026
213 MYOCLONIC EPILEPSY 4 0.0026
214 WOUND COMPLICATION 9 0.0026
215 HYPERNATRAEMIA 13 0.0026
216 HYPERREFLEXIA 9 0.0026
217 ABSCESS LIMB 11 0.0026
218 NECROTISING FASCIITIS 9 0.0026
219 COLOSTOMY 5 0.0025
220 PYELONEPHRITIS 22 0.0025
221 DRUG LEVEL BELOW THERAPEUTIC 14 0.0025
222 EAR HAEMORRHAGE 5 0.0025
223 ARTHRITIS BACTERIAL 10 0.0024
224 OSTEOMYELITIS 44 0.0024
225 DIVERTICULAR PERFORATION 5 0.0024
226 SKIN INDURATION 5 0.0024
227 ACUTE SINUSITIS 4 0.0023
228 NEPHROPATHY TOXIC 26 0.0023
229 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 6 0.0023
230 NYSTAGMUS 12 0.0023
231 AZOTAEMIA 9 0.0023
232 ERYTHEMA MULTIFORME 21 0.0022
233 AREFLEXIA 6 0.0022
234 BLOOD CREATININE DECREASED 7 0.0022
235 PYODERMA GANGRENOSUM 8 0.0022
236 PSEUDOMONAS INFECTION 19 0.0022
237 VASCULAR DEVICE INFECTION 10 0.0022
238 THROMBOCYTOSIS 8 0.0022
239 LUNG CONSOLIDATION 6 0.0021
240 RENAL TUBULAR DISORDER 6 0.0021
241 HUMAN HERPESVIRUS 6 INFECTION 4 0.0021
242 DYSPEPSIA 208 0.0021
243 NEUROLOGICAL SYMPTOM 12 0.0021
244 DECUBITUS ULCER 17 0.0021
245 PURULENCE 4 0.0021
246 BICYTOPENIA 4 0.0020
247 SEIZURE 232 0.0020
248 CEREBRAL ATROPHY 8 0.0020
249 ANORECTAL DISORDER 4 0.0020
250 HEPATITIS ACUTE 13 0.0020
251 HYPERPARATHYROIDISM SECONDARY 5 0.0020
252 DISORIENTATION 79 0.0020
253 BRAIN ABSCESS 5 0.0020
254 DYSPHORIA 10 0.0020
255 HEPATOCELLULAR INJURY 28 0.0020
256 PROSTATITIS 6 0.0020
257 DRUG LEVEL INCREASED 32 0.0019
258 SEROTONIN SYNDROME 37 0.0019
259 PULSELESS ELECTRICAL ACTIVITY 8 0.0019
260 LUNG ABSCESS 4 0.0019
261 ELECTROENCEPHALOGRAM ABNORMAL 6 0.0019
262 EXFOLIATIVE RASH 5 0.0019
263 UNRESPONSIVE TO STIMULI 49 0.0019
264 HYPERPYREXIA 8 0.0019
265 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
266 ENCEPHALITIS 13 0.0019
267 MALNUTRITION 21 0.0019
268 COAGULOPATHY 31 0.0019
269 ABSCESS INTESTINAL 4 0.0019
270 CHOLECYSTITIS INFECTIVE 5 0.0018
271 HYPERAMMONAEMIA 9 0.0018
272 DERMATITIS EXFOLIATIVE 9 0.0018
273 NECROSIS 10 0.0018
274 ANTIPSYCHOTIC DRUG LEVEL INCREASED 5 0.0018
275 PRODUCT USE IN UNAPPROVED INDICATION 434 0.0017
276 BLOOD CREATININE ABNORMAL 6 0.0017
277 FAILURE TO THRIVE 9 0.0017
278 NEUROLOGICAL DECOMPENSATION 4 0.0017
279 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 4 0.0017
280 METABOLIC ACIDOSIS 55 0.0017
281 STEVENS-JOHNSON SYNDROME 38 0.0017
282 SCAR 29 0.0017
283 DEVICE RELATED INFECTION 26 0.0017
284 LACUNAR INFARCTION 4 0.0017
285 LEUKOCYTOSIS 30 0.0017
286 DRUG-INDUCED LIVER INJURY 51 0.0016
287 STAPHYLOCOCCAL BACTERAEMIA 7 0.0016
288 SYSTEMIC CANDIDA 4 0.0016
289 HAEMODYNAMIC INSTABILITY 12 0.0016
290 BONE MARROW FAILURE 32 0.0016
291 SUBARACHNOID HAEMORRHAGE 16 0.0016
292 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 6 0.0016
293 SEPTIC SHOCK 68 0.0016
294 MULTI-ORGAN FAILURE 27 0.0016
295 URINARY TRACT DISORDER 7 0.0016
296 SEPSIS 173 0.0015
297 HYPERBILIRUBINAEMIA 16 0.0015
298 HYPOALBUMINAEMIA 12 0.0015
299 SKIN NECROSIS 8 0.0015
300 DYSARTHRIA 58 0.0015
301 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0015
302 LUNG OPACITY 4 0.0015
303 LOCALISED OEDEMA 7 0.0015
304 ANAL FISTULA 8 0.0015
305 CREATININE RENAL CLEARANCE DECREASED 6 0.0015
306 HYDRONEPHROSIS 11 0.0015
307 CLUMSINESS 4 0.0015
308 AUTOIMMUNE HAEMOLYTIC ANAEMIA 5 0.0015
309 ABSCESS 23 0.0014
310 TUBULOINTERSTITIAL NEPHRITIS 27 0.0014
311 LOGORRHOEA 5 0.0014
312 STAPHYLOCOCCAL SEPSIS 7 0.0014
313 JAUNDICE CHOLESTATIC 5 0.0014
314 NECK MASS 4 0.0014
315 CHOLECYSTITIS ACUTE 8 0.0014
316 ANAEMIA 268 0.0014
317 RASH MACULO-PAPULAR 31 0.0014
318 TOXIC SKIN ERUPTION 14 0.0014
319 BONE LESION 5 0.0014
320 MUSCLE SPASTICITY 17 0.0014
321 TOXIC EPIDERMAL NECROLYSIS 21 0.0014
322 RALES 8 0.0014
323 PRODUCT LABEL CONFUSION 8 0.0014
324 BLOOD BILIRUBIN INCREASED 37 0.0014
325 DRUG ERUPTION 24 0.0014
326 ACUTE RESPIRATORY FAILURE 26 0.0014
327 PYREXIA 467 0.0013
328 CYTOMEGALOVIRUS VIRAEMIA 6 0.0013
329 LEUKOENCEPHALOPATHY 5 0.0013
330 ALTERED STATE OF CONSCIOUSNESS 29 0.0013
331 FISTULA 15 0.0013
332 GANGRENE 8 0.0013
333 CENTRAL VENOUS CATHETERISATION 4 0.0013
334 CATHETER SITE INFECTION 5 0.0013
335 HALLUCINATION, AUDITORY 21 0.0013
336 THERAPEUTIC PRODUCT EFFECT DELAYED 6 0.0013
337 DIABETIC FOOT 4 0.0013
338 FIBROSIS 4 0.0013
339 SMALL INTESTINAL OBSTRUCTION 16 0.0013
340 HYPOMAGNESAEMIA 18 0.0013
341 CHOLANGITIS 8 0.0013
342 DEPRESSED LEVEL OF CONSCIOUSNESS 51 0.0013
343 JAW DISORDER 7 0.0013
344 WHITE BLOOD CELL COUNT INCREASED 49 0.0013
345 VENOUS THROMBOSIS 5 0.0013
346 LYMPHOPENIA 18 0.0013
347 PNEUMONIA FUNGAL 5 0.0013
348 BILE DUCT STONE 4 0.0013
349 HEPATITIS 32 0.0012
350 CHOLESTASIS 24 0.0012
351 RESPIRATORY DISTRESS 34 0.0012
352 BACTERIAL SEPSIS 4 0.0012
353 HAEMOLYTIC ANAEMIA 11 0.0012
354 AGITATION 90 0.0012
355 HYPOPHOSPHATAEMIA 9 0.0012
356 BREATH SOUNDS ABNORMAL 6 0.0012
357 HYPERVOLAEMIA 6 0.0012
358 AGRANULOCYTOSIS 22 0.0012
359 LIP OEDEMA 5 0.0012
360 DRUG LEVEL DECREASED 12 0.0012
361 HYPERTHERMIA 9 0.0012
362 PETIT MAL EPILEPSY 6 0.0012
363 THROMBOCYTOPENIA 131 0.0012
364 PURULENT DISCHARGE 5 0.0012
365 BRONCHOPNEUMONIA 4 0.0012
366 CEREBRAL ISCHAEMIA 6 0.0012
367 MULTIPLE ORGAN DYSFUNCTION SYNDROME 33 0.0012
368 INTERNATIONAL NORMALISED RATIO ABNORMAL 4 0.0012
369 DRUG INTERACTION 184 0.0012
370 APNOEA 9 0.0012
371 GRANULOMA 4 0.0012
372 STAPHYLOCOCCAL INFECTION 38 0.0012
373 NO THERAPEUTIC RESPONSE 14 0.0011
374 MUSCLE CONTRACTIONS INVOLUNTARY 4 0.0011
375 SKIN LESION 31 0.0011
376 CYST 14 0.0011
377 VITAMIN D DEFICIENCY 11 0.0011
378 NEUTROPENIA 152 0.0011
379 LEUKOPENIA 55 0.0011
380 CUTANEOUS VASCULITIS 4 0.0011
381 DELUSION 17 0.0011
382 INTESTINAL ISCHAEMIA 6 0.0011
383 PSYCHOMOTOR HYPERACTIVITY 18 0.0011
384 RENAL FAILURE ACUTE 46 0.0011
385 STREPTOCOCCAL INFECTION 6 0.0011
386 ARTHRITIS INFECTIVE 5 0.0011
387 TENDON INJURY 4 0.0011
388 ACUTE RESPIRATORY DISTRESS SYNDROME 19 0.0011
389 BACTERIAL INFECTION 20 0.0011
390 ANGIOPATHY 6 0.0011
391 FLANK PAIN 10 0.0011
392 ASPERGILLUS INFECTION 7 0.0011
393 GENERALISED OEDEMA 13 0.0010
394 ABDOMINAL PAIN 244 0.0010
395 KIDNEY TRANSPLANT REJECTION 5 0.0010
396 HERPES VIRUS INFECTION 6 0.0010
397 TACHYPNOEA 14 0.0010
398 MUSCLE RUPTURE 4 0.0010
399 HYPOXIA 36 0.0010
400 LUNG INFILTRATION 9 0.0010
401 PURPURA 9 0.0010
402 LARGE INTESTINE PERFORATION 7 0.0010
403 CHOLECYSTITIS 12 0.0010
404 HYPERTRANSAMINASAEMIA 7 0.0010
405 RASH GENERALISED 26 0.0010
406 ERYTHEMA 205 0.0010
407 NODULE 13 0.0010
408 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5 0.0010
409 WEIGHT DECREASED 274 0.0010
410 INTESTINAL PERFORATION 11 0.0010
411 MENTAL DISORDER 42 0.0010
412 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0010
413 THERAPY PARTIAL RESPONDER 15 0.0010
414 RASH PUSTULAR 7 0.0010
415 EPSTEIN-BARR VIRUS INFECTION 6 0.0010
416 EOSINOPHIL COUNT INCREASED 8 0.0010
417 RESPIRATORY FAILURE 70 0.0010
418 PETECHIAE 10 0.0010
419 CONSTIPATION 208 0.0010
420 HYPOCALCAEMIA 18 0.0010
421 BRAIN OEDEMA 12 0.0009
422 PSYCHOTIC DISORDER 28 0.0009
423 ACUTE KIDNEY INJURY 145 0.0009
424 GASTRIC ULCER 18 0.0009
425 PANCREATITIS ACUTE 21 0.0009
426 HYPOGLYCAEMIA 45 0.0009
427 INCORRECT PRODUCT STORAGE 12 0.0009
428 RHABDOMYOLYSIS 38 0.0009
429 SPINAL OSTEOARTHRITIS 8 0.0009
430 PHYSICAL DISABILITY 4 0.0009
431 MENINGITIS 6 0.0009
432 LACTIC ACIDOSIS 29 0.0009
433 CARDIOMEGALY 11 0.0009
434 LIVER FUNCTION TEST ABNORMAL 26 0.0009
435 MENINGITIS ASEPTIC 4 0.0009
436 PAPILLOEDEMA 4 0.0009
437 PRODUCT LABEL ISSUE 6 0.0009
438 COMA 42 0.0009
439 TREATMENT FAILURE 73 0.0009
440 DRUG INEFFECTIVE 1161 0.0009
441 GENERALISED ERYTHEMA 5 0.0009
442 NEUTROPHIL COUNT INCREASED 9 0.0009
443 ACUTE HEPATIC FAILURE 12 0.0009
444 INCORRECT PRODUCT ADMINISTRATION DURATION 19 0.0009
445 HAEMOGLOBIN INCREASED 4 0.0009
446 DRUG LEVEL ABOVE THERAPEUTIC 4 0.0009
447 PNEUMONIA BACTERIAL 8 0.0009
448 ISCHAEMIA 4 0.0009
449 LYMPHOEDEMA 6 0.0009
450 METABOLIC DISORDER 5 0.0009
451 SPEECH DISORDER 45 0.0009
452 URINARY TRACT INFECTION 145 0.0008
453 DECREASED INTEREST 5 0.0008
454 BLOOD ALKALINE PHOSPHATASE INCREASED 21 0.0008
455 MUSCLE RIGIDITY 10 0.0008
456 PROTHROMBIN TIME PROLONGED 5 0.0008
457 HYPOVOLAEMIC SHOCK 4 0.0008
458 HUMERUS FRACTURE 4 0.0008
459 DERMATITIS BULLOUS 6 0.0008
460 BLOOD CREATININE INCREASED 54 0.0008
461 PANCYTOPENIA 46 0.0008
462 DEMENTIA 23 0.0008
463 END STAGE RENAL DISEASE 15 0.0008
464 ASPIRATION 9 0.0008
465 THROMBOTIC MICROANGIOPATHY 8 0.0008
466 PNEUMOTHORAX 13 0.0008
467 INCORRECT DOSAGE ADMINISTERED 4 0.0008
468 LIVER INJURY 20 0.0008
469 HEPATOMEGALY 8 0.0008
470 PANCREATITIS 43 0.0008
471 NASAL POLYPS 4 0.0008
472 MYOPATHY 7 0.0008
473 OLIGURIA 5 0.0008
474 LOCAL SWELLING 14 0.0008
475 HYPOKALAEMIA 37 0.0008
476 VEIN DISORDER 4 0.0008
477 HYPERKALAEMIA 28 0.0008
478 CYTOKINE RELEASE SYNDROME 16 0.0008
479 PNEUMOCYSTIS JIROVECII PNEUMONIA 8 0.0008
480 TROPONIN INCREASED 6 0.0008
481 TOE AMPUTATION 4 0.0008
482 MASS 11 0.0008
483 SHOCK 18 0.0008
484 CYTOMEGALOVIRUS INFECTION 13 0.0008
485 PHLEBITIS 4 0.0008
486 RENAL FAILURE CHRONIC 6 0.0008
487 CACHEXIA 4 0.0008
488 PERIPHERAL VASCULAR DISORDER 4 0.0008
489 ELECTROLYTE IMBALANCE 9 0.0008
490 INCOHERENT 5 0.0008
491 ASPARTATE AMINOTRANSFERASE INCREASED 41 0.0008
492 CANDIDA INFECTION 13 0.0008
493 ALANINE AMINOTRANSFERASE INCREASED 47 0.0008
494 BLOOD CREATINE PHOSPHOKINASE INCREASED 22 0.0008
495 RASH PAPULAR 17 0.0008
496 BLOOD ALBUMIN DECREASED 6 0.0008
497 PLEURAL EFFUSION 46 0.0008
498 RENAL CYST 6 0.0008
499 CARDIAC FAILURE ACUTE 5 0.0007
500 HEPATIC ENCEPHALOPATHY 7 0.0007
501 POST-TRAUMATIC STRESS DISORDER 5 0.0007
502 LIVER FUNCTION TEST INCREASED 16 0.0007
503 ANAL ABSCESS 4 0.0007
504 POSTOPERATIVE WOUND INFECTION 5 0.0007
505 SHOCK HAEMORRHAGIC 6 0.0007
506 PRODUCT PRESCRIBING ISSUE 16 0.0007
507 CELLULITIS 37 0.0007
508 ABNORMAL FAECES 6 0.0007
509 HICCUPS 6 0.0007
510 HEPATIC FAILURE 22 0.0007
511 NEPHROTIC SYNDROME 5 0.0007
512 ECCHYMOSIS 5 0.0007
513 CEREBRAL HAEMORRHAGE 26 0.0007
514 HYPERKERATOSIS 4 0.0007
515 ATELECTASIS 7 0.0007
516 PNEUMONIA ASPIRATION 18 0.0007
517 TRANSAMINASES INCREASED 16 0.0007
518 HEART RATE ABNORMAL 4 0.0007
519 BLOOD UREA INCREASED 12 0.0007
520 HAEMODIALYSIS 6 0.0007
521 ACUTE MYOCARDIAL INFARCTION 21 0.0007
522 BLOOD CALCIUM DECREASED 8 0.0007
523 BLADDER DISORDER 7 0.0007
524 ANGIOEDEMA 31 0.0007
525 HYPERTONIA 4 0.0007
526 BLOOD MAGNESIUM DECREASED 6 0.0007
527 HYPOVOLAEMIA 4 0.0007
528 PRODUCT PREPARATION ERROR 14 0.0007
529 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 6 0.0007
530 ATAXIA 8 0.0007
531 DYSTONIA 13 0.0007
532 RASH ERYTHEMATOUS 32 0.0007
533 TRANSFUSION 7 0.0007
534 MOUTH ULCERATION 14 0.0007
535 FUNGAL INFECTION 22 0.0007
536 HYPOTENSION 130 0.0006
537 DEFORMITY 6 0.0006
538 MOBILITY DECREASED 46 0.0006
539 CHILLS 75 0.0006
540 DISSEMINATED INTRAVASCULAR COAGULATION 9 0.0006
541 FEBRILE NEUTROPENIA 42 0.0006
542 TRICUSPID VALVE INCOMPETENCE 5 0.0006
543 HEPATIC CYTOLYSIS 8 0.0006
544 ENTERITIS 4 0.0006
545 TRANSPLANT REJECTION 5 0.0006
546 OCCUPATIONAL EXPOSURE TO PRODUCT 4 0.0006
547 LOCALISED INFECTION 15 0.0006
548 MALAISE 270 0.0006
549 OFF LABEL USE 539 0.0006
550 DYSKINESIA 25 0.0006
551 PLATELET COUNT INCREASED 8 0.0006
552 NERVOUS SYSTEM DISORDER 19 0.0006
553 TACHYCARDIA 54 0.0006
554 ABASIA 15 0.0006
555 VENTRICULAR TACHYCARDIA 10 0.0006
556 RENAL FAILURE 80 0.0006
557 RESTLESSNESS 22 0.0006
558 GAIT INABILITY 20 0.0006
559 MUSCULAR WEAKNESS 68 0.0006
560 DYSURIA 22 0.0006
561 QUALITY OF LIFE DECREASED 8 0.0006
562 BRONCHIECTASIS 4 0.0006
563 NEUROLEPTIC MALIGNANT SYNDROME 7 0.0006
564 PALLOR 16 0.0006
565 EYE MOVEMENT DISORDER 4 0.0006
566 HEPATOTOXICITY 13 0.0006
567 CARDIAC ARREST 48 0.0006
568 PERITONITIS 12 0.0006
569 ASCITES 17 0.0006
570 COORDINATION ABNORMAL 8 0.0006
571 WOUND 16 0.0006
572 OXYGEN SATURATION DECREASED 32 0.0006
573 IMMUNOSUPPRESSION 5 0.0006
574 PAIN IN JAW 16 0.0006
575 DIALYSIS 8 0.0006
576 SINUS TACHYCARDIA 8 0.0006
577 PAIN 345 0.0006
578 SECRETION DISCHARGE 7 0.0006
579 JAUNDICE 15 0.0006
580 POOR QUALITY SLEEP 12 0.0006
581 DERMATITIS ALLERGIC 7 0.0006
582 LETHARGY 32 0.0006
583 ANAL INCONTINENCE 5 0.0006
584 TONGUE DISORDER 4 0.0006
585 HYPOKINESIA 8 0.0006
586 FAECES SOFT 4 0.0005
587 FLUID OVERLOAD 8 0.0005
588 RENAL IMPAIRMENT 46 0.0005
589 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
590 URINARY INCONTINENCE 16 0.0005
591 HEPATIC FUNCTION ABNORMAL 20 0.0005
592 HYPOAESTHESIA ORAL 8 0.0005
593 HAEMATOTOXICITY 5 0.0005
594 DERMATITIS CONTACT 6 0.0005
595 PROTEINURIA 10 0.0005
596 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9 0.0005
597 LIPASE INCREASED 4 0.0005
598 MUSCLE TWITCHING 12 0.0005
599 LIMB INJURY 14 0.0005
600 VASCULITIS 6 0.0005
601 PARKINSONISM 5 0.0005
602 SPLENOMEGALY 6 0.0005
603 TREMOR 85 0.0005
604 THERAPY NON-RESPONDER 23 0.0005
605 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 28 0.0005
606 URINARY RETENTION 17 0.0005
607 CYANOSIS 8 0.0005
608 BODY TEMPERATURE DECREASED 5 0.0005
609 ATRIAL FIBRILLATION 49 0.0005
610 NAUSEA 397 0.0005
611 BLOOD TEST ABNORMAL 7 0.0005
612 DEVICE OCCLUSION 7 0.0005
613 EYELID PTOSIS 5 0.0005
614 TOOTH ABSCESS 5 0.0005
615 INFECTION 71 0.0005
616 SLUGGISHNESS 5 0.0005
617 ADVERSE EVENT 45 0.0005
618 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
619 CHOLELITHIASIS 16 0.0005
620 INITIAL INSOMNIA 5 0.0005
621 DRUG INTOLERANCE 47 0.0005
622 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 4 0.0005
623 OSTEONECROSIS OF JAW 12 0.0005
624 TEMPERATURE INTOLERANCE 5 0.0005
625 NEUROPATHY PERIPHERAL 46 0.0005
626 PERICARDIAL EFFUSION 11 0.0005
627 UPPER GASTROINTESTINAL HAEMORRHAGE 8 0.0005
628 INCONTINENCE 5 0.0005
629 HEMIPARESIS 8 0.0005
630 MYELOSUPPRESSION 17 0.0005
631 RENAL PAIN 5 0.0005
632 HYPOPHAGIA 12 0.0005
633 PLATELET COUNT DECREASED 50 0.0005
634 ROTATOR CUFF SYNDROME 6 0.0005
635 BLOOD POTASSIUM DECREASED 14 0.0005
636 DECREASED ACTIVITY 5 0.0005
637 KIDNEY INFECTION 9 0.0005
638 DYSPHAGIA 43 0.0005
639 LOSS OF CONSCIOUSNESS 58 0.0005
640 BRADYCARDIA 24 0.0005
641 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10 0.0005
642 HAEMARTHROSIS 4 0.0004
643 OEDEMA 24 0.0004
644 SOMNOLENCE 89 0.0004
645 CONDITION AGGRAVATED 134 0.0004
646 EXOSTOSIS 4 0.0004
647 NEPHROLITHIASIS 20 0.0004
648 RESPIRATORY ARREST 12 0.0004
649 IRON DEFICIENCY ANAEMIA 4 0.0004
650 PRODUCT USE ISSUE 81 0.0004
651 SWELLING FACE 28 0.0004
652 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 10 0.0004
653 LUNG DISORDER 21 0.0004
654 COGNITIVE DISORDER 20 0.0004
655 MANIA 7 0.0004
656 BLINDNESS UNILATERAL 6 0.0004
657 ARTERIOSCLEROSIS 4 0.0004
658 EATING DISORDER 9 0.0004
659 CHRONIC KIDNEY DISEASE 32 0.0004
660 WRIST FRACTURE 5 0.0004
661 SWOLLEN TONGUE 13 0.0004
662 ADRENAL INSUFFICIENCY 5 0.0004
663 EAR PAIN 8 0.0004
664 CARDIAC FAILURE 33 0.0004
665 HEPATIC ENZYME INCREASED 28 0.0004
666 ASTHENIA 154 0.0004
667 MELAENA 9 0.0004
668 INFLAMMATION 21 0.0004
669 THERAPY CHANGE 4 0.0004
670 CARDIO-RESPIRATORY ARREST 17 0.0004
671 CARDIOMYOPATHY 6 0.0004
672 RASH PRURITIC 22 0.0004
673 HAEMATOCRIT DECREASED 8 0.0004
674 ANAPHYLACTIC REACTION 22 0.0004
675 EMPHYSEMA 4 0.0004
676 PERITONITIS BACTERIAL 4 0.0004
677 LYMPHOCYTE COUNT DECREASED 7 0.0004
678 ABDOMINAL PAIN LOWER 10 0.0004
679 MOTOR DYSFUNCTION 4 0.0004
680 NO ADVERSE EVENT 71 0.0004
681 GOUT 7 0.0004
682 RIB FRACTURE 8 0.0004
683 HIATUS HERNIA 5 0.0004
684 PNEUMONIA 125 0.0004
685 INTERNATIONAL NORMALISED RATIO INCREASED 11 0.0004
686 C-REACTIVE PROTEIN INCREASED 14 0.0004
687 SEDATION 10 0.0004
688 HEADACHE 239 0.0004
689 BEDRIDDEN 5 0.0004
690 AGGRESSION 19 0.0004
691 POOR QUALITY PRODUCT ADMINISTERED 4 0.0004
692 ABNORMAL BEHAVIOUR 15 0.0004
693 DISEASE RECURRENCE 18 0.0004
694 JOINT DISLOCATION 4 0.0004
695 OEDEMA PERIPHERAL 46 0.0004
696 ULCER 6 0.0004
697 PREMATURE DELIVERY 6 0.0004
698 DYSSTASIA 11 0.0004
699 HEPATIC STEATOSIS 7 0.0004
700 HYPONATRAEMIA 21 0.0004
701 HEPATIC CIRRHOSIS 7 0.0004
702 INTESTINAL OBSTRUCTION 14 0.0004
703 MUSCLE TIGHTNESS 6 0.0004
704 BALANCE DISORDER 32 0.0004
705 HAEMOGLOBIN DECREASED 38 0.0004
706 DEEP VEIN THROMBOSIS 24 0.0004
707 BLOOD URINE PRESENT 7 0.0004
708 SKIN LACERATION 4 0.0004
709 DEHYDRATION 49 0.0004
710 IMPAIRED HEALING 12 0.0004
711 APHASIA 11 0.0004
712 DENTAL CARIES 4 0.0004
713 VERTIGO 22 0.0004
714 DIVERTICULITIS 10 0.0004
715 LIP SWELLING 12 0.0004
716 GASTROINTESTINAL HAEMORRHAGE 30 0.0004
717 HAEMORRHOIDS 7 0.0004
718 DRUG ADMINISTRATION ERROR 11 0.0004
719 HYPERGLYCAEMIA 13 0.0004
720 FALL 118 0.0004
721 MITRAL VALVE INCOMPETENCE 4 0.0004
722 RED BLOOD CELL COUNT DECREASED 10 0.0003
723 ANAPHYLACTIC SHOCK 9 0.0003
724 MYOCARDITIS 4 0.0003
725 SKIN ULCER 9 0.0003
726 HAEMATOMA 9 0.0003
727 DECREASED APPETITE 80 0.0003
728 EYELID OEDEMA 4 0.0003
729 RASH 150 0.0003
730 RASH MACULAR 12 0.0003
731 BODY TEMPERATURE INCREASED 7 0.0003
732 ANHEDONIA 9 0.0003
733 HEART RATE DECREASED 12 0.0003
734 METASTASES TO LIVER 6 0.0003
735 DIARRHOEA 215 0.0003
736 MENTAL IMPAIRMENT 8 0.0003
737 ECONOMIC PROBLEM 5 0.0003
738 SYNCOPE 33 0.0003
739 OSTEOPENIA 5 0.0003
740 BONE DISORDER 6 0.0003
741 GENERAL PHYSICAL HEALTH DETERIORATION 38 0.0003
742 CEREBRAL INFARCTION 8 0.0003
743 DRUG DISPENSING ERROR 5 0.0003
744 RESPIRATORY DEPRESSION 4 0.0003
745 TOXICITY TO VARIOUS AGENTS 55 0.0003
746 BLOOD GLUCOSE ABNORMAL 6 0.0003
747 HYPERCALCAEMIA 4 0.0003
748 PRURITUS GENERALISED 7 0.0003
749 LIMB DISCOMFORT 10 0.0003
750 FAECES DISCOLOURED 7 0.0003
751 ILEUS 4 0.0003
752 BLISTER 18 0.0003
753 INTENTIONAL PRODUCT USE ISSUE 28 0.0003
754 TARDIVE DYSKINESIA 9 0.0003
755 BLOOD SODIUM DECREASED 6 0.0003
756 SUICIDAL IDEATION 29 0.0003
757 ARRHYTHMIA 15 0.0003
758 URTICARIA 53 0.0003
759 MUSCLE ATROPHY 4 0.0003
760 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
761 PRODUCTIVE COUGH 15 0.0003
762 POST PROCEDURAL COMPLICATION 6 0.0003
763 HIP FRACTURE 10 0.0003
764 BLOOD POTASSIUM INCREASED 5 0.0003
765 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
766 EPISTAXIS 23 0.0003
767 ORAL HERPES 6 0.0003
768 DEAFNESS 8 0.0003
769 MEDICATION ERROR 17 0.0003
770 SINUS DISORDER 6 0.0003
771 PHOTOSENSITIVITY REACTION 5 0.0003
772 SOPOR 4 0.0003
773 ABDOMINAL DISTENSION 31 0.0003
774 FACE OEDEMA 5 0.0003
775 CHEST DISCOMFORT 30 0.0003
776 MUSCULOSKELETAL DISCOMFORT 5 0.0003
777 TOOTH LOSS 6 0.0003
778 FEELING COLD 8 0.0003
779 DERMATITIS 6 0.0003
780 BLOOD PRESSURE DECREASED 19 0.0003
781 BRONCHOSPASM 4 0.0003
782 SUBDURAL HAEMATOMA 4 0.0003
783 NIGHT SWEATS 9 0.0003
784 CARDIOGENIC SHOCK 4 0.0003
785 HYPOACUSIS 12 0.0003
786 IMPAIRED QUALITY OF LIFE 4 0.0003
787 DISTURBANCE IN ATTENTION 15 0.0003
788 GAIT DISTURBANCE 53 0.0003
789 HYPERTENSION 58 0.0003
790 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
791 RENAL INJURY 8 0.0003
792 PULMONARY MASS 4 0.0003
793 IMMUNODEFICIENCY 4 0.0003
794 WHITE BLOOD CELL COUNT DECREASED 29 0.0003
795 MUCOSAL INFLAMMATION 7 0.0003
796 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9 0.0003
797 PRODUCT AVAILABILITY ISSUE 6 0.0003
798 HAEMATURIA 9 0.0003
799 SLEEP APNOEA SYNDROME 5 0.0003
800 FEAR 7 0.0003
801 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
802 THROAT TIGHTNESS 7 0.0003
803 MUSCULOSKELETAL CHEST PAIN 4 0.0003
804 EJECTION FRACTION DECREASED 4 0.0003
805 PNEUMONITIS 7 0.0003
806 ACUTE MYELOID LEUKAEMIA 4 0.0003
807 INJURY 18 0.0003
808 FLUID RETENTION 13 0.0003
809 SINUSITIS 26 0.0003
810 HYPERSENSITIVITY 47 0.0003
811 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 18 0.0003
812 PRODUCT PRESCRIBING ERROR 6 0.0003
813 BLOOD PRESSURE ABNORMAL 5 0.0003
814 CYSTITIS 8 0.0003
815 HAEMOPTYSIS 7 0.0003
816 HYPOTHYROIDISM 8 0.0003
817 SKIN EXFOLIATION 21 0.0002
818 STOMATITIS 15 0.0002
819 MYALGIA 42 0.0002
820 PRESYNCOPE 6 0.0002
821 NEUTROPHIL COUNT DECREASED 10 0.0002
822 HYPERSOMNIA 7 0.0002
823 BRONCHITIS 18 0.0002
824 EXPIRED PRODUCT ADMINISTERED 8 0.0002
825 SKIN DISORDER 8 0.0002
826 DYSPNOEA EXERTIONAL 9 0.0002
827 LABORATORY TEST ABNORMAL 7 0.0002
828 DYSPNOEA 134 0.0002
829 RESPIRATORY DISORDER 7 0.0002
830 PARANOIA 4 0.0002
831 AMNESIA 15 0.0002
832 HAEMORRHAGE 24 0.0002
833 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
834 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
835 HEAD DISCOMFORT 4 0.0002
836 CARDIAC FAILURE CONGESTIVE 18 0.0002
837 VOMITING 105 0.0002
838 PULMONARY OEDEMA 10 0.0002
839 OVERDOSE 48 0.0002
840 HEART RATE IRREGULAR 5 0.0002
841 PULMONARY EMBOLISM 21 0.0002
842 TOOTHACHE 4 0.0002
843 WRONG TECHNIQUE IN DRUG USAGE PROCESS 8 0.0002
844 MALIGNANT NEOPLASM PROGRESSION 22 0.0002
845 THERAPY CESSATION 11 0.0002
846 GASTROINTESTINAL DISORDER 19 0.0002
847 FOOT FRACTURE 4 0.0002
848 BLOOD PRESSURE INCREASED 32 0.0002
849 BLOOD PRESSURE FLUCTUATION 5 0.0002
850 DRUG PRESCRIBING ERROR 4 0.0002
851 MUSCLE SPASMS 38 0.0002
852 PRESCRIBED OVERDOSE 4 0.0002
853 CHEST PAIN 38 0.0002
854 NASAL CONGESTION 12 0.0002
855 NIGHTMARE 7 0.0002
856 UPPER LIMB FRACTURE 4 0.0002
857 THROMBOSIS 16 0.0002
858 HAEMATEMESIS 5 0.0002
859 INCORRECT ROUTE OF DRUG ADMINISTRATION 7 0.0002
860 PRURITUS 75 0.0002
861 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
862 DIPLOPIA 5 0.0002
863 RESPIRATORY TRACT INFECTION 5 0.0002
864 HEART RATE INCREASED 19 0.0002
865 HEAD INJURY 6 0.0002
866 COUGH 53 0.0002
867 OSTEOARTHRITIS 8 0.0002
868 COLORECTAL CANCER 9 0.0002
869 BLOOD GLUCOSE DECREASED 9 0.0002
870 MOVEMENT DISORDER 6 0.0002
871 PRODUCT QUALITY ISSUE 25 0.0002
872 INSOMNIA 49 0.0002
873 PRODUCT DISPENSING ERROR 4 0.0002
874 MUSCULOSKELETAL STIFFNESS 16 0.0002
875 SWELLING 17 0.0002
876 DIZZINESS 90 0.0002
877 ORAL PAIN 4 0.0002
878 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
879 INCORRECT DRUG ADMINISTRATION DURATION 5 0.0002
880 CHROMATURIA 4 0.0002
881 LOWER RESPIRATORY TRACT INFECTION 8 0.0002
882 PERIPHERAL SWELLING 27 0.0002
883 FATIGUE 136 0.0002
884 NEOPLASM PROGRESSION 6 0.0002
885 MUSCULOSKELETAL PAIN 9 0.0002
886 RENAL DISORDER 8 0.0002
887 COVID-19 30 0.0002
888 HYPERHIDROSIS 22 0.0002
889 OSTEOPOROSIS 7 0.0002
890 PREMATURE BABY 5 0.0002
891 DEATH 142 0.0002
892 ACCIDENTAL OVERDOSE 6 0.0002
893 DISCOMFORT 10 0.0002
894 HOSPITALISATION 25 0.0002
895 FEMUR FRACTURE 5 0.0002
896 VAGINAL HAEMORRHAGE 7 0.0002
897 ABDOMINAL DISCOMFORT 27 0.0002
898 HYPOAESTHESIA 24 0.0002
899 FLATULENCE 9 0.0002
900 DIABETES MELLITUS 12 0.0002
901 MATERNAL EXPOSURE DURING PREGNANCY 14 0.0002
902 SLEEP DISORDER 11 0.0002
903 DYSPHONIA 9 0.0002
904 SURGERY 9 0.0002
905 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 8 0.0002
906 PARAESTHESIA 24 0.0002
907 GASTRITIS 4 0.0002
908 BLOOD CHOLESTEROL INCREASED 7 0.0002
909 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 27 0.0001
910 IRRITABILITY 9 0.0001
911 DYSGEUSIA 11 0.0001
912 FLUSHING 15 0.0001
913 INFLUENZA LIKE ILLNESS 12 0.0001
914 DRUG DOSE OMISSION 24 0.0001
915 PALPITATIONS 17 0.0001
916 ABNORMAL DREAMS 4 0.0001
917 DISEASE PROGRESSION 17 0.0001
918 WITHDRAWAL SYNDROME 6 0.0001
919 BURNING SENSATION 10 0.0001
920 BACK PAIN 33 0.0001
921 LYMPHADENOPATHY 5 0.0001
922 OROPHARYNGEAL PAIN 13 0.0001
923 ARTHRITIS 11 0.0001
924 ALOPECIA 27 0.0001
925 INFLUENZA 15 0.0001
926 EYE SWELLING 5 0.0001
927 ADVERSE DRUG REACTION 12 0.0001
928 ANXIETY 38 0.0001
929 PAIN IN EXTREMITY 39 0.0001
930 EMOTIONAL DISTRESS 16 0.0001
931 THERAPEUTIC RESPONSE DECREASED 8 0.0001
932 ABDOMINAL PAIN UPPER 27 0.0001
933 MEMORY IMPAIRMENT 18 0.0001
934 TINNITUS 6 0.0001
935 TREATMENT NONCOMPLIANCE 7 0.0001
936 OCULAR HYPERAEMIA 6 0.0001
937 ARTHROPATHY 7 0.0001
938 NECK PAIN 7 0.0001
939 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
940 DRY MOUTH 10 0.0001
941 POLLAKIURIA 5 0.0001
942 BONE PAIN 7 0.0001
943 UNEVALUABLE EVENT 9 0.0001
944 TYPE 2 DIABETES MELLITUS 4 0.0001
945 WHEEZING 7 0.0001
946 VISION BLURRED 16 0.0001
947 DEVICE LEAKAGE 5 0.0001
948 ILL-DEFINED DISORDER 7 0.0001
949 ECZEMA 6 0.0001
950 DEPRESSION 26 0.0001
951 FEELING HOT 7 0.0001
952 INCORRECT DOSE ADMINISTERED 26 0.0001
953 DEPRESSED MOOD 6 0.0001
954 LIVER DISORDER 5 0.0001
955 EXPOSURE DURING PREGNANCY 7 0.0001
956 THROAT IRRITATION 5 0.0001
957 PANIC ATTACK 4 0.0001
958 NASOPHARYNGITIS 20 0.0001
959 CONTUSION 10 0.0001
960 ARTHRALGIA 43 0.0001
961 INTERSTITIAL LUNG DISEASE 5 0.0001
962 WEIGHT INCREASED 23 0.0001
963 FEELING ABNORMAL 24 0.0001
964 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
965 DEVICE BREAKAGE 4 0.0001
966 FOETAL EXPOSURE DURING PREGNANCY 8 0.0001
967 UNDERDOSE 7 0.0001
968 NERVOUSNESS 5 0.0001
969 CEREBROVASCULAR ACCIDENT 16 0.0001
970 DEVICE DISLOCATION 4 0.0001
971 MYOCARDIAL INFARCTION 16 0.0001
972 EYE PAIN 5 0.0001
973 EYE IRRITATION 5 0.0001
974 PRODUCT DOSE OMISSION 5 0.0001
975 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
976 SKIN BURNING SENSATION 5 0.0001
977 HERPES ZOSTER 4 0.0001
978 DRUG WITHDRAWAL SYNDROME 6 0.0001
979 ILLNESS 7 0.0001
980 CATARACT 4 0.0001
981 CARDIAC DISORDER 6 0.0001
982 MIGRAINE 6 0.0001
983 INJECTION SITE PAIN 19 0.0001
984 ASTHMA 7 0.0001
985 BLOOD GLUCOSE INCREASED 11 0.0001
986 PRODUCT STORAGE ERROR 5 0.0001
987 VISUAL IMPAIRMENT 7 0.0001
988 THERAPY INTERRUPTED 4 0.0001
989 PRODUCT DOSE OMISSION ISSUE 16 0.0001
990 DRY SKIN 6 0.0000
991 JOINT SWELLING 5 0.0000
992 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
993 INJECTION SITE ERYTHEMA 4 0.0000
994 DRUG DEPENDENCE 4 0.0000
995 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000